Apontis Pharma AG (APPH) — Strategic Asset Allocation Index
Apontis Pharma AG (APPH) has a Strategic Asset Allocation Index of 0.1% as of June 2023. Strategic assets (PP&E of €37.35K plus long-term investments of €-) total €37.35K, measured against net assets of €38.04 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Apontis Pharma AG Strategic Asset Allocation Index (2019–2021)
This chart shows how Apontis Pharma AG's Strategic Asset Allocation Index has evolved across 3 annual periods from 2019 to 2021. As of June 2023, the index stands at 0.1%, representing strategic assets of €37.35K against net assets of €38.04 Million EUR. Explore Apontis Pharma AG operating cash flow efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Apontis Pharma AG (2019–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Apontis Pharma AG from 2019 to 2021, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Apontis Pharma AG.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.0% | €18.68K | €18.68K | €- | €40.71 Million | ▼ -1.1 pp |
| 2020 | 1.2% | €41.12K | €41.12K | €- | €3.46 Million | ▼ -0.3 pp |
| 2019 | 1.5% | €67.50K | €67.50K | €- | €4.64 Million | — |